Medical isotope crisis could ease if Canadian reactor is allowed to reopen
This article was originally published in Clinica
Executive Summary
The Canadian Nuclear Safety Commission (CNSC) is expected to decide this week whether the Chalk River reactor can re-start production of the medical isotope molybdenum-99 (Mo-99).